From: Quality measures for the care of patients with lateral epicondylalgia
Clinical quality measures | n | Kappa index | General agreement percentage (%) | ||
---|---|---|---|---|---|
Inter-rater | Intra-rater | Inter-rater | Intra-rater | ||
I. Patient exam | Â | Â | Â | Â | Â |
1. Physical examination: percentage of patients with LE for whom the affected tendon was examined (at least orthopedic tests). | 80 | - | - | 100 | 100 |
2. Pain assessment: percentage of patients with LE who had pain assessment upon initiation of a new treatment. | 80 | - | - | 95 | 100 |
3. Functional assessment: percentage of patients with LE who had functional assessment upon initiation of a new treatment. | 80 | - | - | 85 | 95 |
II. Educational interventions | Â | Â | Â | Â | Â |
1. Education: percentage of patients with LE for whom their health provider gave them education and counselling for risk factor reduction strategies. | 80 | 0.8 | 0.9 | - | - |
III. 1. Pharmacological therapy | Â | Â | Â | Â | Â |
1. Pharmacological therapy for LE: percentage of patients who received pharmacological therapy for LE and who received NSAIDs as first line. | 75 | - | - | 100 | 100 |
2. Prophylaxis for gastrointestinal bleeding: percentage of patients with NSAIDs for LE who concomitantly received inhibitors (e.g. proton pump inhibitor, misoprostol, etc.). | 24 | 0.9 | 1 | - | - |
III. 2. Physical therapy | Â | Â | Â | Â | Â |
1. Physical therapy for LE: percentage of patients who received physical therapy for LE and who received a program of exercise therapy as first line. | 42 | - | - | 95 | 100 |
2. Physical therapy for LE: percentage of patients who received physical therapy for LE and who received manual therapy as first line. | 42 | 0.9 | 1 | - | - |
3. Physical therapy for LE: percentage of patients who received physical therapy for LE and who received laser therapy as first line. | 42 | 0.9 | 1 | - | - |
4. Time of referral: percentage of patients with LE who received corticosteroid injection and who initiated a multimodal program of physical therapy within 14Â days of the injection. | 17 | 1 | 1 | - | - |
III. 3. Other therapeutic interventions | Â | Â | Â | Â | Â |
1. Platelet-rich plasma (PRP) therapy for LE: percentage of patients who received PRP therapy for LE and who received PRP therapy as first line (*). | 1 | N/A. | N/A. | N/A. | N/A. |
2. Surgery intervention for LE: percentage of patients who were symptomatic after a minimum of 6–12 months of conservative therapies and who underwent surgery (*). | 14 | N/A. | N/A. | N/A. | N/A. |